HSP27 and HSP70 serum and urine levels in patients suffering from chronic kidney disease

Clinica Chimica Acta

Volumn 413, Issue 1-2, 2012, Pages 282-286

  Lebherz Eichinger, Diana ^a   Ankersmit, Hendrik J ^a   Hacker, Stefan ^a   Hetz, Hubert ^a   Kimberger, Oliver ^a   Schmidt, Elisabeth M ^a   Reiter, Thomas ^a   Hörl, Walter H ^a   Haas, Martin ^a   Krenn, Claus G ^a   Roth, Georg A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biomarkers; Chronic kidney disease; Heat shock proteins; HSP27; HSP70

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED;

EID: 82955198430     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.10.010     Document Type: Article

References (36)

1. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
2. Collins A.J., Foley R.N., Herzog C., et al. Excerpts from the US Renal Data System 2009 annual data report. Am J Kidney Dis 2010, 55(S1-420):A426-A427.
3. Himmelfarb J., Stenvinkel P., Ikizler T.A., Hakim R.M. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002, 62:1524-1538.
4. Fujii H., Nakai K., Fukagawa M. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Ther Apher Dial 2011, 15:125-128.
5. Shah S.V., Baliga R., Rajapurkar M., Fonseca V.A. Oxidants in chronic kidney disease. J Am Soc Nephrol 2007, 18:16-28.
6. Capeillere-Blandin C., Gausson V., Descamps-Latscha B., Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004, 1689:91-102.
7. Himmelfarb J., McMonagle E., McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000, 58:2571-2578.
8. Mattson M.P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal 2006, 8:1997-2006.
9. Iadecola C., Alexander M. Cerebral ischemia and inflammation. Curr Opin Neurol 2001, 14:89-94.
10. Meyer T.W., Hostetter T.H. Uremia. N Engl J Med 2007, 357:1316-1325.
11. Arya R., Mallik M., Lakhotia S.C. Heat shock genes - integrating cell survival and death. J Biosci 2007, 32:595-610.
12. De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock 1999, 11:1-12.
13. Lanneau D., de Thonel A., Maurel S., Didelot C., Garrido C. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 2007, 1:53-60.
14. Arrigo A.P., Virot S., Chaufour S., Firdaus W., Kretz-Remy C., Diaz-Latoud C. Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. Antioxid Redox Signal 2005, 7:414-422.
15. Garrido C., Ottavi P., Fromentin A., et al. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1997, 57:2661-2667.
16. Rogalla T., Ehrnsperger M., Preville X., et al. Regulation of Hsp27 oligomerization, chaperone function, and protective activity against oxidative stress/tumor necrosis factor alpha by phosphorylation. J Biol Chem 1999, 274:18947-18956.
17. Bender T.O., Riesenhuber A., Endemann M., et al. Correlation between HSP-72 expression and IL-8 secretion in human mesothelial cells. Int J Artif Organs 2007, 30:199-203.
18. Neuhofer W., Lugmayr K., Fraek M.L., Beck F.X. Regulated overexpression of heat shock protein 72 protects Madin-Darby canine kidney cells from the detrimental effects of high urea concentrations. J Am Soc Nephrol 2001, 12:2565-2571.
19. Maddock A.L., Westenfelder C. Urea induces the heat shock response in human neuroblastoma cells. J Am Soc Nephrol 1996, 7:275-282.
20. Musial K., Szprynger K., Szczepanska M., Zwolinska D. The heat shock protein profile in children with chronic kidney disease. Perit Dial Int 2010, 30:227-232.
21. Marzec L., Zdrojewski Z., Liberek T., et al. Expression of Hsp72 protein in chronic kidney disease patients. Scand J Urol Nephrol 2009, 43:400-408.
22. Ankersmit H.J., Deicher R., Moser B., et al. Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol 2001, 125:142-148.
23. Moser B., Roth G., Brunner M., et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 2003, 308:581-585.
24. Roth G.A., Lebherz-Eichinger D., Ankersmit H.J., et al. Increased total cytokeratin-18 serum and urine levels in chronic kidney disease. Clin Chim Acta 2011, 412:713-717.
25. Chironi G.N., Boulanger C.M., Simon A., Dignat-George F., Freyssinet J.M., Tedgui A. Endothelial microparticles in diseases. Cell Tissue Res 2009, 335:143-151.
26. Twfeek D.M., Zaki S.M. Role of tumour necrosis factor alpha and CD95 as markers of apoptosis in pathogenesis of pediatrics renal diseases. Egypt J Immunol 2005, 12:155-165.
27. Musial K., Zwolinska D. Heat shock proteins in chronic kidney disease. Pediatr Nephrol 2011 Jul, 26(7):1031-1037. [Electronic publication ahead of print 2010 Dec 31, Review].
28. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994, 12:991-1045.
29. Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002, 20:395-425.
30. Bruemmer-Smith S., Stuber F., Schroeder S. Protective functions of intracellular heat-shock protein (HSP) 70-expression in patients with severe sepsis. Intensive Care Med 2001, 27:1835-1841.
31. Andrie R.P., Bauriedel G., Braun P., Hopp H.W., Nickenig G., Skowasch D. Prevalence of intimal heat shock protein 60 homologues in unstable angina and correlation with anti-heat shock protein antibody titers. Basic Res Cardiol 2011 Jun, 106(4):657-665. [Electronic publication ahead of print 2011 Mar 18].
32. Hacker S., Lambers C., Hoetzenecker K., et al. Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. Clin Lab 2009, 55:31-40.
33. McGrath L.B., Locke M., Cane M., Chen C., Ianuzzo C.D. Heat shock protein (HSP 72) expression in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1995, 109:370-376.
34. Pizon M.T., Gburek T., Pizon M., Sztefko K. Kinetics of plasma heat shock protein HSP-70 release in coronary artery surgery: on-pump versus off-pump. Minerva Chir 2006, 61:483-491.
35. Szerafin T., Hoetzenecker K., Hacker S., et al. Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg 2008, 85:80-87.
36. Lopez-Novoa J.M., Martinez-Salgado C., Rodriguez-Pena A.B., Lopez-Hernandez F.J. Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives. Pharmacol Ther 2010, 128:61-81.